You are here
Sources
MedEffect Canada - Advisories and Recalls for Health Professionals
- Doribax (doripenem for injection) - Higher Mortality Rate and a Lower Clinical Cure Rate Observed During a Comparative Clinical Trial 5 days 23 hours old
- VELCADE (bortezomib) - Fatal if Given Intrathecally 6 days 2 hours old
- Celexa (citalopram) - Association with abnormal heart rhythms - Lundbeck Canada Inc. 6 days 20 hours old
MedEffet Canada - Avis et retraits pour les professionnels de la santé
- Doribax (doripénem pour injection) - Taux de mortalité plus élevé et taux de guérison plus faible observés durant une étude clinique comparative 5 days 23 hours old
- VELCADE (bortézomib) - L'administration intrathécale est mortelle 6 days 2 hours old
- Celexa (citalopram) - Association à des anomalies du rythme cardiaque - Lundbeck Canada Inc. 6 days 22 hours old
MedEffect Canada - Advisories and Recalls for the Public
- Celexa (citalopram) - Association with abnormal heart rhythms 6 days 22 hours old
- Foreign Product Alerts 1 week 4 days old
- RASILEZ (aliskiren) and RASILEZ HCT (aliskiren/hydrochlorothiazide) - Potential Risks of Cardiovascular and Renal Adverse Events in Patients with Type 2 Diabetes 1 week 6 days old
